SamaCare, a workflow platform for providers of specialty medicines, announced that it has secured $17 million in an oversubscribed Series B investment round.
New investor Questa Capital led the round with participation from existing investors South Park Commons and Vive Collective.
what it does
The California-based company provides a cloud-based workflow automation platform to help providers obtain prior authorization, verify enrollment, and verify benefits for specialty medications. We also work with pharmaceutical companies to provide data analytics to help improve access to treatments.
The company will use the funding to expand its Script-to-Therapy operating system, which leverages AI for administrative tasks, creates post-prescription workflows, gathers data insights, and enhances collaboration between provider offices.
“SamaCare plans to invest the funds to build a comprehensive script-to-therapy operating system to enhance the capabilities of our specialty pre-certification platform for patients, providers and pharmaceutical companies,” said Syam Palakurthy, founder and CEO of SamaCare. . MobiHealthNews By email.
“This means building more collaboration capabilities, AI-driven guidance, and data insights into our platform to comprehensively help our customers overcome the administrative and financial obstacles to getting patients started on treatment.”
market snapshot
SamaCare closed a $12 million Series A round in 2022.
Another company that offers a workflow automation platform is Cerner. In 2021, the enterprise software giant was acquired by Oracle for $28.3 billion and also acquired Epic, which provides clinical and administrative workflow tools.
